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The United States ranks worse on maternal mortality than
other high-resource countries (Tikkanen, Gunja, FitzGerald, &
Zephyrin, 2020). It is one of few countries where maternal
mortality has not improved in recent decades (GBD 2015
Maternal Mortality Collaborators, 2016). Racial/ethnic and
geographic inequities in maternal mortality are substantial and
persistent. Black and Native American individuals are particularly burdened, with at least two- to threefold higher mortality
than the rest of the population (Admon et al., 2018). Severe
maternal morbidity (SMM) is a sentinel or near-miss maternal
health outcome proximate in severity to maternal mortality
(Figure 1). SMM encompasses unexpected outcomes of labor and
birth that put women most at risk of dying, such as eclampsia,
hemorrhage, cardiovascular events, sepsis, and organ failure
(American College of Obstetricians, Gynecologists, the Society for
Maternal-Fetal Medicine, Kilpatrick, & Ecker, 2016). SMM is
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50–100 times more common than maternal mortality, affecting
1–2% of people giving birth, and thus more feasible to study. Like
maternal mortality, SMM has increased in recent decades
(although the reasons for the increases are uncertain) (Leonard,
Main, &Carmichael, 2019) and disproportionately affects
women of color (Admon et al., 2018). A better understanding of
how and why SMM occurs is key to improving maternal health
and preventing maternal mortality. This includes recognizing
both clinical and social drivers of maternal morbidity (e.g.,
racism), and their modiﬁability.
The objective of this commentary was to call attention to
challenges to identifying population-level strategies for preventing SMM and its inequities, and to propose solutions. We
focus on challenges to conducting research related to SMM
within the U.S. context, although the points raised have broader
global applicability. The challenges discussed include 1) the
conceptual frameworks used to understand SMM, 2) deﬁning
SMM, and 3) the availability of data to assess SMM. By addressing
these issues, we aim to advance research and efforts to improve
health across the life course for people who give birth.
Here, we use terms that are both gendered (e.g., maternal)
and gender-neutral (e.g., individual) to be inclusive of the identities of all persons with capacity for pregnancy and birth, which
span the gender spectrum (Moseson et al., 2020).

1049-3867/$ - see front matter Ó 2021 Jacobs Institute of Women's Health, George Washington University. Published by Elsevier Inc. All rights reserved.
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Figure 1. Continuum of maternal morbidity, by severity. (Adapted from NYC
Department of Health & Mental Hygiene. 2016. Severe Maternal Morbidity in NYC,
2008–12. New York, NY.)

Conceptual and Theoretical Frameworks to Guide SMM Research
We conceptualize SMM and its inequities within a multidimensional causal chain of events framework that spans the
“macrosocial” (i.e., structural and societal factors) to the “microclinical” (i.e., pathways from speciﬁc clinical precursors to speciﬁc SMM indicators) (Figure 2). Transformative, sustainable
improvements require identifying effective interventions that
span this entire continuum: preventing acute progression to lifethreatening situations and interrupting higher-order social processes that threaten health. Transformative change will thus
require centering on equity, which in turn requires acknowledging our historical legacy (Halfon et al., 2014; Kramer et al.,
2019) rooted in the historical context of the enslavement of
Black Americans, the genocide of Native and Indigenous Americans, and a system of structural racism (i.e., mutually reinforcing
systems that foster racial discrimination and differential access

to resources and opportunities) that has led to intergenerational
trauma for minoritized groups in the United States (Bailey,
Feldman, & Bassett, 2021).
Several conceptual and theoretical frameworks and approaches are particularly important to guiding research on SMM
(Table 1). First, SMM research should be grounded within a
broader context of reproductive health that acknowledges its
multilevel, life course, and intergenerational nature (recommendation 1A). Reproductive health is inﬂuenced by experiences
that span the entire life course and multiple generations, and
that occur at multiple levels (e.g., individual, family, neighborhood, societal) (Halfon & Hochstein, 2002; Lu & Halfon, 2003;
McLeroy, Bibeau, Steckler, & Glanz, 1988). For example, adverse
childhood events, as well as intergenerational poverty, may
affect adult reproductive outcomes (Mersky & Lee, 2019).
Second, research should be centered on principles of health
and racial equity, which can be informed by several movements
and theories (recommendation 1B). Research should be grounded in reproductive justice and an explicit acknowledgment that
health-related inequities arise from social forces rather than
innate biologic differences. Reproductive justice is a framework
created by Black women that emphasizes the human right to
maintain personal bodily autonomy, to have or not have children,
and to parent one’s children in safe, supportive communities
(Black Women Scholars and the Research Working Group of the
Black Mamas Matter Alliance, 2020; Ross, 2017). As articulated
by Critical Race Theory and Krieger’s EcoSocial model, disparities
emanate from a historical context of bias and racism, rooted in
societal power structures, that is manifested over time and
across generations in multiple aspects of one’s social context and
living environment (e.g., social policy, health care quality, and
safety) (Krieger, 2020). The resulting exposures are embodied
over the life course and ultimately lead to greater biologic
vulnerability and adverse health outcomes (Roberts, 1998;
Krieger, 2020). Furthermore, health equity must be acknowledged, understood, and improved along multiple intersectional
dimensions, including sexual and gender identiﬁcation,
disability, socioeconomic status, and migrant and/or documentation status. Frameworks to guide the incorporation of these
tenets into research exist and should be used (e.g., Public Health

Figure 2. Conceptual framework for describing multilevel pathways to severe maternal morbidity (SMM) and its inequities.
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Table 1
Recommendations for Improving Population-based Research on SMM
1. Conceptual and theoretical frameworks to guide SMM research
1A. Reproductive health
SMM research should be grounded in the broader context of reproductive health
(not just “pregnancy” health), acknowledging that reproductive health is
 Multilevel - Supported by the Social-Ecological Model, this framework
recognizes the inﬂuence of multilevel domains of inﬂuence on
reproductive health, including individual, neighborhood, health
system, and societal factors (McLeroy et al., 1988).
 Life course health – Pregnancy outcomes like SMM are affected by life
course experiences, and SMM may in turn affect subsequent life course
health (Lu & Halfon, 2003).
 Intergenerational health – Historic context of one’s family and society
affect the reproductive health of current and subsequent generations
(e.g., intergenerational trauma, slavery, genocide of Native populations)
(Halfon & Hochstein, 2002; McLeroy et al., 1988).
1B. Health and racial equity
Given stark disparities by race and social disadvantage, SMM research should
be centered on achieving equity, within a framework that is informed by
multiple relevant movements and theories, including, for example, Critical
Race Theory, EcoSocial Theory, Intersectionality, and Reproductive Justice
(Black Women Scholars and the Research Working Group of the Black Mamas
Matter Alliance, 2020; Roberts, 1998; Ford & Airhihenbuwa, 2010; Krieger,
2020; Ross, 2017) [see references for further explication].
1C. Community-engaged research
SMM research should be guided by principles of community-engaged
research, which acknowledge that contributions from people with lived
experience and highest burden, at every stage of the research process, are
essential to its effectiveness (Ortiz et al., 2020; Wang et al., 2020b).
2. Deﬁning SMM
2A. Timing of SMM
 SMM indicators should characterize severe complications that arise
during pregnancy or postpartum, and not situations at risk of leading to
severe complications.
2C. Indicators
 Standardized approaches that link precursor clinical conditions with
SMM events are needed to fully understand the causes of SMM, how
best to approach it analytically, and how to prevent it.
2C. Transparency
 Research should provide a clear deﬁnition of SMM, report all codes and
criteria that are used, and use existing validated indices whenever possible.
 Coding experts should be included in the development and revision of
SMM indices.
 If transfusion is included in the deﬁnition of SMM and volume of
transfusion is not available, ﬁndings should be reported with and
without including transfusion as an indicator.
 Research should state the timing of SMM events that are included,
provide justiﬁcation, and discuss potential concomitant limitations.
2D. Continuum of care
 When possible, research should include SMM events that arise during
pregnancy or childbirth, through at least 42 days postpartum, and the
approach should be clearly described.
 Further research is needed that compares SMM that emerges during the
prenatal, peripartum, and postpartum periods.
3. Data improvements
 Improve the availability of data resources that
- Allow rigorous characterization of SMM
- Include critical individual-level sociodemographic variables (e.g.,
maternal race-ethnicity, age, parity, socioeconomic status)
and
- Enable characterization of social and structural determinants (see
Figure 2 for examples).
 Some suggested strategies are as follows:
- Develop state-based datasets that link vital records with maternal and
infant hospital discharge records, including indicators of where people
live so that social and structural determinants can be studied.
- Improve the quality of maternal health information recorded in vital
records. Using current versions of birth and fetal death certiﬁcates to
study SMM is not recommended.
- Improve the quality of social determinant information in hospital
discharge records.
- Fund the exploration of birthing people’s and communities’ perspectives and priorities regarding SMM.
Abbreviation: SMM, severe maternal morbidity.
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Critical Race praxis, intersectionality) (Ford & Airhihenbuwa,
2010).
Third, principles of community-engaged research, which
acknowledge that contributions from people who represent and
directly advocate for those who have experienced SMM, and
especially from groups bearing the highest burden of SMM, are
essential to effective, impactful research and intervention
(Wang, Glazer, Sofaer, Balbierz, & Howell, 2020b) and are needed
across all stages of the research process, from inception to
dissemination (Ortiz et al., 2020) (recommendation 1C). Declaration and integration of these principles into study designs and
dissemination, by inclusive research teams that center the voices
and experiences of socially marginalized investigators and
communities, will help ensure that we ask meaningful questions
that yield meaningful answers and do not perpetuate racism and
other forms of oppression (Boyd, Lindo, Weeks, & McLemore,
2020; Hardeman, Karbeah, & Kozhimannil, 2020; Julian et al.,
2020; Vyas, Einstein, & Jones, 2020). Future research should
center the perspectives of those affected by SMM and implement
their priorities for research and intervention (Eniola, Nack, Niles,
Morton, & Searing, 2020; Wang et al., 2020b).
In summary, SMM and its inequities should be conceptualized
within a multidimensional causal chain of events framework
that intentionally incorporates multiple relevant theoretical
frameworks (see Table 1.) Although not every study or prevention strategy will address all of the complexities we have
described, grounding in their essence will produce better
research that is more likely to lead to sustainable, equitable
improvement of maternal health.
Deﬁning SMM
Another important obstacle to understanding SMMdoverall
and with respect to equitydis variability in how SMM is
conceptually deﬁned and operationalized or identiﬁed from data
(England et al., 2020; Knight & Joseph, 2020). The American
College of Obstetricians & Gynecologists deﬁnes SMM as unintended outcomes of the process of labor and delivery that have
signiﬁcant short-term or long-term consequences for maternal
health and can be considered a near miss for maternal mortality
(American College of Obstetricians, Gynecologists et al., 2016).
SMM cases are typically identiﬁed from a composite of SMM
indicators (i.e., complications or events that qualify as SMM). For
example, the Centers for Disease Control and Prevention (CDC)
SMM index includes a broad array of indicators that can be obtained from International Classiﬁcation of Disease (ICD) codes in
hospital discharge data (CDC, 2017). In contrast, the World
Health Organization deﬁnition focuses on organ dysfunction
criteria, which tend to require laboratory results (Say, Souza, &
Pattinson, 2009). Greater consensus is needed regarding processes to ascertain cases (be it from case review or administrative
data) and what conditions to include, as discussed elsewhere
(Knight, 2020; Knight & Joseph, 2020). Here we point out some
more general conceptual points that we believe are important to
improving consistency and clarity in how SMM is deﬁned.
First, we recommend that SMM indicators should characterize severe complications that arise during or following pregnancy, and not conditions at risk of severe complications
(recommendation 2A). In this case, preexisting conditions such
as sickle-cell anemia, HIV disease, or severe obesity would not be
considered SMM, but sickle-cell crisis, HIV-related complications, or acute myocardial infarction might be. This view guided
the development of an SMM index by the CDC, which is used
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commonly in U.S. studies of SMM but has not been applied in all
studies of SMM (CDC, 2017; Chantry et al., 2020; Dzakpasu et al.,
2020).
Second, we recommend development of standardized approaches that link precursor clinical conditions with SMM indicators (recommendation 2B). SMM-deﬁning events may or
may not directly indicate the immediate underlying clinical
condition that preceded SMM. For example, major respiratory
events typically identiﬁed as SMM, such as pulmonary edema or
acute respiratory distress syndrome, can be caused by varied
precursor clinical conditions, such as preeclampsia, infection,
cardiac disease, or hemorrhage. In some cases, the connection
between SMM and its proximal clinical precursor is obvious (e.g.,
eclampsia follows preeclampsia). Either way, determining the
clinical precursor to SMM is a separate step from identifying the
SMM event itself. This step requires further attention, as it will
help us understand pathways leading to SMM and opportunities
for prevention.
Third, we recommend transparency in how SMM is deﬁned
and reported (recommendation 2C). SMM measures vary in the
indicators they include, which can lead to considerable variability in prevalence estimates (England et al., 2020; Snowden
et al., 2021). The use of auxiliary factors to reﬁne case identiﬁcation, such as length of hospital stay or intensive care unit
admission, also varies across studies (Snowden et al., 2021). One
example is blood transfusion. Transfusion is included in the CDC
index, but ICD codes do not indicate transfusion volume. This
lack of speciﬁcity can result in misclassiﬁcation when transfusion, which may or may not qualify as “severe,” is the only
SMM indicator present (Main et al., 2016); indeed, approximately half of cases have transfusion as their only indicator in
studies using the CDC index. CDC thus currently reports SMM
with and without including transfusion as an indicator. Inconsistency in the actual codes selected to identify indicators within
similar coding systems is another problem. For example, the CDC
index and the Bateman index use some different ICD codes for
the same indicators (Snowden et al., 2021). Even when using the
same indices, variability in coding systems and their application
may affect cross-study or cross-population comparison (Chantry
et al., 2020). To facilitate comparisons across studies, we
recommend the following: detailed description of how SMM is
deﬁned; inclusion of medical coding experts in the development
of SMM indices; use of existing, validated indices; and reporting
of ﬁndings with and without including transfusion as an
indicator.
Fourth, we recommend SMM research and intervention
address the continuum of care from the prenatal through postpartum periods (recommendation 2D). Clarity about SMM
timing is important. SMM may emerge during pregnancy, at the
time of childbirth, or postpartum. A recent review of SMM definitions reported that only about half of prior studies of SMM
actually stated the range of timing of SMM-deﬁning events
(England et al., 2020). Most studies are limited to data from
childbirth hospitalizations, which capture most but not all cases
(Girsen et al., 2020). Further complicating this matter is inconsistency in deﬁning the length of the postpartum period, typically varying from 42 days to 1 year (National Academies of
Sciences, Engineering, and Medicine, 2020). The extent of
underascertainment of SMM that occurs postpartum, such as
what types of SMM events are most likely to be missed, and
whether cases are more likely to be missed among certain subgroups, is unknown. We recommend that studies clarify timing
for ascertaining SMM and include cases that emerge during

childbirth, and afterward whenever possible; that differences in
these two sets of cases should be considered when possible; that
studies clearly state their data sources and timing for ascertaining SMM; and that researchers conduct additional studies of
SMM that occurs after birth hospitalizations.
In sum, greater consensus and consistency in how SMM is
deﬁned is needed, both within the United States and beyond, in
order for the ﬁeld to truly move forward (Knight, 2020; Knight &
Joseph, 2020). A recent study described a process to develop
consensus-based criteria for SMM using hospital discharge data
among several European countries, albeit focused on a few select
indicators (Chantry et al., 2020). The study serves as an excellent
learning template for others and reinforces how essential
collaboration is to achieving progress.
Data Improvements
Another roadblock to progress in understanding SMM is data
availability. In the United States, hospital discharge or claims
data typically contain sufﬁcient coding of procedures and conditions to identify SMM as it is currently deﬁned. However, this
type of dataset often lacks information on patient experience and
important nonclinical factors that are likely part of the pathways
leading to SMM, such as social-structural, sociodemographic,
environmental, and behavioral factors. For example, the U.S.
National Inpatient Sample (NIS) is a publicly available data
source from a representative sample of U.S. hospitalizations that
can provide nationally representative SMM rates. However, the
NIS (and most hospital discharge data) does not include factors
such as parity, education, geography, or gestational age at birth
(all of which are available from U.S. vital records). Before 2012,
the NIS had substantial missing data on race/ethnicity (>20%),
but this limitation has been rectiﬁed. Of note, some deﬁnitions of
SMM rely on data that are not available in discharge records,
such as vital sign measurements and laboratory values
(American College of Obstetricians, Gynecologists et al., 2016;
Say et al., 2009; World Health Organization, 2011); however, the
degree to which such additional information would increase
validity of existing SMM indices like the CDC index is unclear,
and the feasibility of its inclusion is also uncertain. Many largescale data sets (including NIS) are also lacking longitudinally
linked data, for example, to reﬂect postpartum health care encounters or to link multiple births over time to the same woman.
To understand and eliminate inequities, we need to be able to
study social and structural determinants of health, many of
which include features of where people live (Kramer et al., 2019).
These features include aspects of the health care system (e.g.,
health care quality and availability), characteristics of the physical and built environment (e.g., socioeconomic resources, crime,
green space, food availability, pollution), and policies (e.g., laws
regarding access to reproductive health care). Hospital discharge
data do not typically indicate where a patient lived (before,
during, or after pregnancy). Since 2012, even state of residence is
not available from the NIS. Thus, we currently cannot readily
compare the prevalence of SMM across states, and our understanding of the contribution of social determinants to SMM is
limited (Wang, Glazer, Howell, & Janevic, 2020a). County of birth
can be obtained from U.S. vital records, and in some states, more
reﬁned indicators of where a woman lives (e.g., ZIP code) may be
available with permission, because the maternal address at the
time of birth is part of the vital record. However, in the United
States, vital records (birth certiﬁcates and fetal death certiﬁcates)
alone do not provide sufﬁcient information to understand SMM
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(Luke, Brown, Liu, Diop, & Stern, 2018; Snowden et al., 2021).
They currently include checkboxes for a few maternal conditions
that occur during the childbirth hospitalization and are indicative of SMM (e.g., transfusion). The sensitivity is unacceptably
low; in a study of California births, the sensitivity was 0.08 for
transfusion and 0.07 for sepsis, when comparing birth certiﬁcates with hospital discharge data (Snowden et al., 2021).
Further, the availability of data that address patient experience of
SMM, via quantitative or qualitative data, is limited; producing
high-quality data regarding patient experiences and priorities
requires community involvement and greater attention from
funders. Thus, a major barrier to improving SMM research is the
absence of the types of data needed to study some of its most
important determinants.
Linkage of hospital discharge data (which enable identiﬁcation of SMM cases) and vital records (which can provide data on
sociodemographic variables and where a woman lived) is one
mechanism to improve data availability and quality needed to
study, understand, and address SMM and its inequities. Such
linkages are technically straightforward and highly successful via
probabilistic linkage of variables, such as date, time, and hospital
of birth (>98% success in California) (Herrchen, Gould, & Nesbitt,
1997). Other linkages would also be useful but often less feasible,
such as with prenatal or postpartum outpatient claims records.
The onus of responsibility to make such data available falls
largely on government-funded public health agencies at state
and national levels. Resources are needed to make such data
available, both to create the datasets and to manage data access
and security. These hurdles are difﬁcult to overcome, in light of
competing priorities and tight budgets. Another mechanism is
that hospitals could develop systems to download electronic
health record data straight into the vital record, to improve its
reporting of maternal conditions that are currently included. This
approach could be extended statewide. A third approach is to
better incorporate nonclinical information (e.g., sociodemographics, community resources) into hospital discharge and
electronic health records, following existing recommendations
(Institute of Medicine, 2014).
In sum, some useful data do exist, and the technical challenges to creating accessible data sources for studying SMM are
surmountable. We recommend that mechanisms for creating
more comprehensive data resources to study SMM and social
determinants be developed, and that such development be a
national priority to improve maternal and child health (Table 1).
Conclusions
Reducing SMM is critical to improving maternal health. SMM
is now a national outcome measure for Title V, it is part of new
Healthy People 2030 Goals, and it is one of the few quality indicators that focuses on maternal health (versus neonatal, perinatal, or obstetric care)dall of which attest to the importance of
understanding its causes. To make progress on understanding
SMM, we need a solid conceptual orientation that spans the
continuum of broad structural to speciﬁc clinical factors and
centers equity; better consensus on its deﬁnition and measurement; a conﬂuence of population-level data on SMM, sociodemographic variables, and place; and better understanding of
patient and community experience of SMM. The time is right for
progress, now that the urgency of the U.S. maternal health crisis
is broadly understood. Media attention and public demand to
improve maternal health and achieve racial equity is growing.
Congress has proposed multiple pieces of legislation to improve
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maternal health, including omnibus bills addressing improved
care for Black women, supported by the Black Maternal Health
Caucus. The National Institutes of Health launched its IMPROVE
initiative in 2020, the Patient-Centered Outcomes Research Institute’s reauthorization includes a focus on maternal health, and
the CDC launched its “Hear Her” campaign. The Health Resources
and Services Administration–supported Alliance for Innovation
on Maternal Health initiative and the CDC National Network of
Perinatal Quality Collaboratives support the development and
implementation of toolkits to improve the quality of maternal
care. Heightened intolerance of racism and concerns about the
impact of the COVID-19 pandemic on maternal health and health
equity will likely further galvanize action to improve maternal
health. Documenting and calling attention to the U.S. maternal
health crisis are critical steps on the path to improving maternal
health and mitigating inequities, but they are not sufﬁcient on
their own. Achieving progress toward addressing this largely
preventable crisis requires coordinated, multifaceted action. It is
essential that we act using a multilevel framework informed by
evidence, centered on equity and the voices of the people who
are most affected, to ensure health across the life course for every
person giving birth in the United States.
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